in 26 women receiving either medroxyprogesterone acetate ( depo-provera ) injections or combined oestrogen-progestogen pills for contraception , tests of coagulation and fibrinolysis were performed before treatment , and after 8 , 16 and 24 weeks of therapy .
C0065864
medroxyprogesterone acetate
C0699700
depo-provera